Roger Jeffs - Aug 31, 2022 Form 4/A - Amendment Insider Report for Liquidia Corp (LQDA)

Role
Chief Executive Officer, Director
Signature
/s/ Roger Jeffs
Stock symbol
LQDA
Transactions as of
Aug 31, 2022
Transactions value $
$4,870
Form type
4/A - Amendment
Date filed
4/10/2023, 04:32 PM
Date Of Original Report
Sep 1, 2022
Previous filing
Jun 22, 2022
Next filing
Sep 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LQDA Common Stock Award $4.87K +993 +0.86% $4.90 116K Aug 31, 2022 Direct F3
holding LQDA Common Stock 46.6K Aug 31, 2022 See footnote F1
holding LQDA Common Stock 1.54M Aug 31, 2022 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.
F2 The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.
F3 This amendment is being filed solely to add this footnote 3 and to correct the transaction code in box 3 above. These shares of common stock were acquired on August 31, 2022 through the Liquidia Corporation 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).